{
     "PMID": "28477202",
     "OWN": "NLM",
     "STAT": "In-Process",
     "LR": "20170718",
     "IS": "1573-7365 (Electronic) 0885-7490 (Linking)",
     "VI": "32",
     "IP": "4",
     "DP": "2017 Aug",
     "TI": "Acute and chronic treatment with quetiapine induces antidepressant-like behavior and exerts antioxidant effects in the rat brain.",
     "PG": "1195-1208",
     "LID": "10.1007/s11011-017-0028-y [doi]",
     "AB": "Many studies note that changes in oxidative balance are involved in the pathogenesis of major depressive disorder (MDD) and in the success of some antidepressants. Quetiapine exerts a therapeutic response and induces changes in physiological mechanisms that appear to underlie MDD. The objective of this study was to evaluate the antidepressant and antioxidant effects of quetiapine (20 mg /kg) in adult animals. Sixty minutes after an acute treatment or the last administration of chronic treatment (14 days) with quetiapine, animals were subjected to the forced swimming test (FST) to evaluate mobility parameters. Then, the hippocampus, prefrontal cortex (CPF), amygdala and nucleus accumbens (NAc) were removed for the assessment of oxidative stress parameters. Both acute and chronic treatments exerted antidepressant-like effects. Myeloperoxidase (MPO) activity was reduced in the amygdala after acute treatment and in the hippocampus, PFC and amygdala after chronic treatment. In addition, after chronic treatment, the levels of thiobarbituric reactive species (TBARS) were reduced in the amygdala and NAc, and the protein carbonyl content was reduced in the CPF. Superoxide dismutase (SOD) activity increased in the NAc after acute and chronic treatments. Catalase (CAT) activity increased in the PFC after acute treatment and in the NAc after acute and chronic treatments. The concentration of nitrite/nitrate was lower in the CPF after chronic treatment. These results corroborate the antidepressant effect of quetiapine and indicate that quetiapine exhibits an antioxidant profile, a physiological mechanism that appears be involved in the therapeutic function of quetiapine in individuals resistant to classical antidepressant treatments.",
     "FAU": [
          "Ignacio, Zuleide M",
          "Reus, Gislaine Z",
          "Abelaira, Helena M",
          "de Moura, Airam B",
          "de Souza, Thays G",
          "Matos, Danyela",
          "Goldim, Mariana P",
          "Mathias, Khiany",
          "Garbossa, Leandro",
          "Petronilho, Fabricia",
          "Quevedo, Joao"
     ],
     "AU": [
          "Ignacio ZM",
          "Reus GZ",
          "Abelaira HM",
          "de Moura AB",
          "de Souza TG",
          "Matos D",
          "Goldim MP",
          "Mathias K",
          "Garbossa L",
          "Petronilho F",
          "Quevedo J"
     ],
     "AD": "Laboratorio de Neurociencias, Unidade Academica em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Fisiologia, Farmacologia e Psicopatologia, Campus Chapeco, Universidade Federal da Fronteira Sul, Chapeco, Santa Catarina, Brazil. Laboratorio de Neurociencias, Unidade Academica em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. gislainezilli@hotmail.com. Laboratorio de Neurociencias, Unidade Academica em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Neurociencias, Unidade Academica em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Neurociencias, Unidade Academica em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Neurociencias, Unidade Academica em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Patofisiologia Clinica e Experimental, Universidade do Sul de Santa Catarina, Tubarao, SC, Brazil. Laboratorio de Patofisiologia Clinica e Experimental, Universidade do Sul de Santa Catarina, Tubarao, SC, Brazil. Laboratorio de Patofisiologia Clinica e Experimental, Universidade do Sul de Santa Catarina, Tubarao, SC, Brazil. Laboratorio de Patofisiologia Clinica e Experimental, Universidade do Sul de Santa Catarina, Tubarao, SC, Brazil. Laboratorio de Neurociencias, Unidade Academica em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Center for Translational Psychiatry, Department of Psychiatry and Behavioral Sciences, Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA. Center of Excellence on Mood Disorders, Department of Psychiatry and Behavioral Sciences, Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA. Neuroscience Graduate Program, Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20170506",
     "PL": "United States",
     "TA": "Metab Brain Dis",
     "JT": "Metabolic brain disease",
     "JID": "8610370",
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Animal model of depression",
          "Antioxidant",
          "Major depressive disorder",
          "Oxidative stress",
          "Quetiapine"
     ],
     "EDAT": "2017/05/10 06:00",
     "MHDA": "2017/05/10 06:00",
     "CRDT": [
          "2017/05/07 06:00"
     ],
     "PHST": [
          "2016/12/19 00:00 [received]",
          "2017/05/01 00:00 [accepted]",
          "2017/05/10 06:00 [pubmed]",
          "2017/05/10 06:00 [medline]",
          "2017/05/07 06:00 [entrez]"
     ],
     "AID": [
          "10.1007/s11011-017-0028-y [doi]",
          "10.1007/s11011-017-0028-y [pii]"
     ],
     "PST": "ppublish",
     "SO": "Metab Brain Dis. 2017 Aug;32(4):1195-1208. doi: 10.1007/s11011-017-0028-y. Epub 2017 May 6.",
     "term": "hippocampus"
}